Company Filing History:
Years Active: 2010
Title: Frida Liane Plavnik: Innovator in Protein Identification and Quantification
Introduction
Frida Liane Plavnik is a notable inventor based in São Paulo, Brazil. She has made significant contributions to the field of biochemistry, particularly in the identification and quantification of proteins. Her work has implications for understanding hypertension and renal lesions, showcasing her innovative approach to medical diagnostics.
Latest Patents
Frida holds a patent for a method of identification and quantification of proteins, specifically isoforms of the angiotensin I converting enzyme (ACE). This invention relates to a method that identifies and quantifies the 190-kDa and 90-kDa isoforms in various biological samples, including tissues, cells, and urine. The patent emphasizes the potential of the 90 kDa isoform as a genetic marker for hypertension and its role as a prognostic agent for both primary and secondary renal lesions. This method aims to enhance diagnosis, risk stratification, and therapeutic decision-making in arterial hypertension.
Career Highlights
Frida is affiliated with the Universidade Federal de São Paulo (Unifesp), where she continues her research and innovation in the field of biochemistry. Her academic background and ongoing research contribute to advancements in medical science, particularly in hypertension management.
Collaborations
Frida has collaborated with esteemed colleagues, including Dulce Elena Casarini and Odair Marson. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Frida Liane Plavnik is a pioneering inventor whose work in protein identification and quantification has the potential to transform medical diagnostics related to hypertension. Her contributions to the field underscore the importance of innovation in addressing health challenges.